Company Filing History:
5 out of 8,373 
4 out of 443 
4 out of 2,963 
Years Active: 2020-2024
Title: Yinqing Li: Innovating Gene Manipulation through CRISPR-Cas Systems
Introduction:
In the realm of gene manipulation and CRISPR technology, there are few names as notable as Yinqing Li. Based in Cambridge, Massachusetts, Li has been instrumental in developing and optimizing systems, methods, enzymes, and guide scaffolds for efficient sequence manipulation. With an impressive record of four patents, Li's contributions have enhanced our understanding and application of the revolutionary CRISPR-Cas systems.
Latest Patents:
One of Li's recent patents is titled "Engineering and optimization of systems, methods, enzymes, and guide scaffolds of CAS9 orthologs and variants for sequence manipulation." This invention provides novel systems and methods for altering the expression of target gene sequences and related gene products. It includes structural information on the Cas protein of the CRISPR-Cas system and methods for generating modified components of the CRISPR complex. Li's inventive approach also encompasses the design and use of vectors and components in the CRISPR system, facilitating optimized CRISPR-Cas enzyme systems.
Another significant patent involved "Methods, models, systems, and apparatus for identifying target sequences for Cas enzymes or CRISPR-Cas systems and conveying results thereof." This invention discloses thermodynamic and multiplication methods dedicated to CRISPR-Cas systems, along with the apparatus utilized. By leveraging these methods, researchers can identify target sequences for Cas enzymes and CRISPR-Cas systems more effectively, providing valuable insights into genome editing techniques.
Career Highlights:
Yinqing Li's career highlights are intertwined with prestigious institutions at the forefront of scientific research. Li has made significant contributions during tenures at the Massachusetts Institute of Technology (MIT) and The Broad Institute, Inc. His work at these esteemed institutions has played a crucial role in advancing gene manipulation technologies, specifically within the CRISPR-Cas system.
Collaborations:
Throughout his career, Li has had the opportunity to collaborate with notable experts in the field of gene manipulation. Two significant collaborators include Feng Zhang and Ron Weiss. Feng Zhang is widely recognized for his pioneering work with CRISPR-Cas9 systems, while Ron Weiss is a renowned synthetic biologist. These collaborations have amplified Li's ability to contribute innovative solutions to the field.
Conclusion:
Yinqing Li's mastery of CRISPR-Cas systems and his relentless pursuit of innovation have propelled him to the forefront of gene manipulation research. With a portfolio comprising four patents, including optimized functional CRISPR-Cas enzyme systems and methods for identifying target sequences, Li has solidified his position as a leading figure in the field. Through his career at renowned institutions and collaborations with esteemed scientists, Yinqing Li continues to drive advancements in gene manipulation that will shape the future of biotechnology.